business
Becton, Dickinson and Company Q2 Earnings Call Highlights
Key takeaways
- Becton, Dickinson and Company Q2 Earnings Call Highlights Market Beat Sat, May 9, 2026 at 9:07 PM GMT+7 7 min read BDX ISRG Becton, Dickinson and Company logo Key Points Interested in Becton, Dickinson and Company?
- BD beat Q2 expectations with revenue of $4.7 billion and adjusted EPS of $2.90, and management raised full-year adjusted EPS guidance to $12.52–$12.72 while keeping revenue guidance at low-single-digit growth.
- Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Becton, Dickinson and Company Q2 Earnings Call Highlights Market Beat Sat, May 9, 2026 at 9:07 PM GMT+7 7 min read BDX ISRG Becton, Dickinson and Company logo Key Points Interested in Becton, Dickinson and Company? Here are five stocks we like better.
BD beat Q2 expectations with revenue of $4.7 billion and adjusted EPS of $2.90, and management raised full-year adjusted EPS guidance to $12.52–$12.72 while keeping revenue guidance at low-single-digit growth.
Growth was broad-based across the portfolio, with strong performance in areas like advanced patient monitoring, biologics, PureWick, and interventional products helping offset headwinds from Alaris, vaccines, China, and tariffs.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Saia Q1 2026 earnings exceed expectations
Investing.com
Earnings call transcript: Pacira BioSciences Q1 2026 earnings exceed forecasts
Investing.com
Earnings call transcript: AO Smith Q1 2026 misses earnings, stock dips
Investing.com
Earnings call transcript: UFP Industries Q1 2026: Missed Earnings, Stock Declines
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop